These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 37894970

  • 1. Role of Necroptosis in Intervertebral Disc Degeneration.
    Khaleque MA, Kim JH, Hwang BJ, Kang JK, Quan M, Kim YY.
    Int J Mol Sci; 2023 Oct 18; 24(20):. PubMed ID: 37894970
    [Abstract] [Full Text] [Related]

  • 2. Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.
    Chen J, Kos R, Garssen J, Redegeld F.
    Cells; 2019 Nov 21; 8(12):. PubMed ID: 31766571
    [Abstract] [Full Text] [Related]

  • 3. Spotlight on necroptosis: Role in pathogenesis and therapeutic potential of intervertebral disc degeneration.
    Ran R, Zhang SB, Shi YQ, Dong H, Song W, Dong YB, Zhou KS, Zhang HH.
    Int Immunopharmacol; 2024 Sep 10; 138():112616. PubMed ID: 38959544
    [Abstract] [Full Text] [Related]

  • 4. Understanding necroptosis and its therapeutic target for intervertebral disc degeneration.
    Wang Z, Hu X, Wang W, Li Y, Cui P, Wang P, Kong C, Chen X, Lu S.
    Int Immunopharmacol; 2023 Aug 10; 121():110400. PubMed ID: 37290323
    [Abstract] [Full Text] [Related]

  • 5. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
    Soliman M, Seo JY, Baek YB, Park JG, Kang MI, Cho KO, Park SI.
    J Virol; 2022 Jan 12; 96(1):e0122221. PubMed ID: 34668777
    [Abstract] [Full Text] [Related]

  • 6. Viral-induced neuronal necroptosis: Detrimental to brain function and regulation by necroptosis inhibitors.
    Prasad Panda S, Kesharwani A, Prasanna Mallick S, Prasanth D, Kumar Pasala P, Bharadwaj Tatipamula V.
    Biochem Pharmacol; 2023 Jul 12; 213():115591. PubMed ID: 37196683
    [Abstract] [Full Text] [Related]

  • 7. Necroptosis: A Pathogenic Negotiator in Human Diseases.
    Chaouhan HS, Vinod C, Mahapatra N, Yu SH, Wang IK, Chen KB, Yu TM, Li CY.
    Int J Mol Sci; 2022 Oct 22; 23(21):. PubMed ID: 36361505
    [Abstract] [Full Text] [Related]

  • 8. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z, Feng J, Yu J, Chen G.
    J Cell Sci; 2019 May 20; 132(10):. PubMed ID: 31028177
    [Abstract] [Full Text] [Related]

  • 9. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.
    Jacobsen AV, Pierotti CL, Lowes KN, Au AE, Zhang Y, Etemadi N, Fitzgibbon C, Kersten WJA, Samson AL, van Delft MF, Huang DCS, Sabroux HJ, Lessene G, Silke J, Murphy JM.
    Cell Death Dis; 2022 Apr 01; 13(4):291. PubMed ID: 35365636
    [Abstract] [Full Text] [Related]

  • 10. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
    Yu X, Mao M, Liu X, Shen T, Li T, Yu H, Zhang J, Chen X, Zhao X, Zhu D.
    J Mol Med (Berl); 2020 Apr 01; 98(4):569-583. PubMed ID: 32072232
    [Abstract] [Full Text] [Related]

  • 11. Progress in study on the final executor of necroptosis MLKL and its inhibitors.
    Liu X, Tu H, Peng J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb 28; 48(2):242-251. PubMed ID: 36999471
    [Abstract] [Full Text] [Related]

  • 12. Necroptosis inhibitors: mechanisms of action and therapeutic potential.
    Zhou Y, Cai Z, Zhai Y, Yu J, He Q, He Y, Jitkaew S, Cai Z.
    Apoptosis; 2024 Feb 28; 29(1-2):22-44. PubMed ID: 38001341
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
    Chen H, Fang Y, Wu J, Chen H, Zou Z, Zhang X, Shao J, Xu Y.
    Cell Death Dis; 2018 Aug 29; 9(9):878. PubMed ID: 30158627
    [Abstract] [Full Text] [Related]

  • 15. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils.
    Barbosa LA, Fiuza PP, Borges LJ, Rolim FA, Andrade MB, Luz NF, Quintela-Carvalho G, Lima JB, Almeida RP, Chan FK, Bozza MT, Borges VM, Prates DB.
    Front Immunol; 2018 Aug 29; 9():1818. PubMed ID: 30154785
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase.
    Pierotti CL, Jacobsen AV, Grohmann C, Dempsey RK, Etemadi N, Hildebrand JM, Fitzgibbon C, Young SN, Davies KA, Kersten WJA, Silke J, Lowes KN, Jousset Sabroux H, Huang DCS, van Delft MF, Murphy JM, Lessene G.
    Biochem J; 2023 May 15; 480(9):665-684. PubMed ID: 37115711
    [Abstract] [Full Text] [Related]

  • 19. Significance of Necroptosis in Cartilage Degeneration.
    Khaleque MA, Kim JH, Tanvir MAH, Park JB, Kim YY.
    Biomolecules; 2024 Sep 21; 14(9):. PubMed ID: 39334958
    [Abstract] [Full Text] [Related]

  • 20. Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis.
    Coornaert I, Hofmans S, Devisscher L, Augustyns K, Van Der Veken P, De Meyer GRY, Martinet W.
    Expert Opin Drug Discov; 2018 Jun 21; 13(6):477-488. PubMed ID: 29598451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.